Skip to main content
. 2013 Mar;28(2):115–123. doi: 10.1089/cbr.2012.1268

FIG. 2.

FIG. 2.

The effects of Gefitinib on the phosphorylation of epidermal growth factor receptor (EGFR), AKT, and ERK and expression of BIM in NSCLC cell lines. (A) PC-9 cell. (B) A549 cell. (C) SPC-A1 cell. (D) NCI-H1975 cell. Tumor cells were seeded in six-well plates and treated with Gefitinib for 24 hours, and then cells were lysed, and the lysate was subjected to SDS-PAGE, and probed with indicated antibodies.